metricas
covid
Buscar en
Vacunas (English Edition)
Toda la web
Inicio Vacunas (English Edition) Exploring the intention and hesitancy to receive a booster dose of COVID-19 vacc...
Journal Information
Vol. 24. Issue 4.
Pages 317-325 (October - December 2023)
Share
Share
Download PDF
More article options
Visits
123
Vol. 24. Issue 4.
Pages 317-325 (October - December 2023)
Original article
Exploring the intention and hesitancy to receive a booster dose of COVID-19 vaccine among patients with comorbid disease conditions using a health belief model
Exploración de la intención y la vacilación de recibir una dosis de refuerzo de la vacuna COVID-19 entre pacientes con condiciones comórbidas utilizando un Modelo de creencias de salud
Visits
123
Anmar Al-Taiea,
Corresponding author
altaiianmar@gmail.com

Corresponding author.
, Zekiye Yilmazb
a Clinical Pharmacy Department, Faculty of Pharmacy, Istinye University, Istanbul, Türkiye
b Clinical Pharmacy Department, Faculty of Pharmacy, Acıbadem Mehmet Ali Aydınlar University, Istanbul, Türkiye
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (4)
Table 1. Demographic characteristics of the study participants (N = 162).
Table 2. Patterns regarding the COVID-19 vaccination among the study participants (N = 162).
Table 3. Intention and willingness to receive a booster COVID-19 vaccine based on the HBM among the study participants (N = 162).
Table 4. Correlation between demographic characteristics with the intention to receive booster COVID-19 vaccine among the study participants.
Show moreShow less
Abstract
Background

Despite the fact that the WHO recommends that adults over the age of 18 have to receive a booster dose of the COVID-19 vaccine. The willingness and intention to accept a booster dose of the COVID-19 vaccine remain major issues among the general population, particularly patients with comorbid disease conditions. The aim of this study was to assess the patterns regarding COVID-19 infection and vaccination, along with the intention and hesitancy to receive a booster dose of the COVID-19 vaccine among patients with comorbid disease conditions in Istanbul, Türkiye.

Methods

This was a descriptive, cross-sectional study conducted among patients with comorbid disease conditions using a three-part, structured, validated questionnaire. Vaccine hesitancy from a booster dose of the COVID-19 vaccine was assessed using the Health Belief Model (HBM), based on a 5-point Likert-type scale.

Results

The study enrolled 162 participants with a mean age of 57.2 ± 13.3 years. 97% of the respondents received the COVID-19 vaccine. Almost half of respondents (51.2%) reported receiving information about a booster dose of the COVID-19 vaccine. HBM among the participants with comorbidities showed a significant agreement regarding the perceived susceptibility (P < 0.0001), perceived severity (P < 0.0001) and perceived benefits (P < 0.0001) to receive a booster vaccine dose. There was a statistically significant correlation between the intention to receive a booster vaccine dose and education level (university education; P < 0.0001).

Conclusion

A vast and significant majority of patients with chronic comorbid disease conditions who received the COVID-19 vaccine reported an intention to receive a booster dose.

Keywords:
Booster dose
Comorbid diseases
COVID-19
Pandemic
Vaccine hesitancy
Resumen
Introducción

A pesar de que la OMS recomienda que los adultos mayores de 18 años reciban una dosis de refuerzo de la vacuna contra el COVID-19. La voluntad y la intención de aceptar una dosis de refuerzo de la vacuna COVID-19 siguen siendo problemas importantes entre la población general, en particular los pacientes con enfermedades comórbidas. El objetivo de este estudio fue evaluar los patrones con respecto a la infección y vacunación de COVID-19, junto con la intención y la indecisión de recibir una dosis de refuerzo de la vacuna COVID-19 entre pacientes con enfermedades comórbidas en Estambul, Turquía.

Métodos

Este fue un estudio descriptivo transversal realizado entre pacientes con enfermedades comórbidas utilizando un cuestionario validado, estructurado y de tres partes. La vacilación de la vacuna de una dosis de refuerzo de la vacuna COVID-19 se evaluó utilizando el Modelo de creencias de salud (HBM), basado en una escala tipo Likert de 5 puntos.

Resultados

El estudio inscribió a 162 participantes con una edad media de 57,2 ± 13,3 años. El 97% de los encuestados recibió la vacuna COVID-19. Casi la mitad de los encuestados (51,2%) informaron haber recibido información sobre una dosis de refuerzo de la vacuna contra la COVID-19. HBM entre los participantes con comorbilidades mostró un acuerdo significativo con respecto a la susceptibilidad percibida (P < 0,0001), la gravedad percibida (P < 0,0001) y los beneficios percibidos (P < 0,0001) para recibir una dosis de vacuna de refuerzo. Hubo una correlación estadísticamente significativa entre la intención de recibir una dosis de vacuna de refuerzo y el nivel educativo (educación universitaria; P < 0,0001).

Conclusión

Una gran y significativa mayoría de los pacientes con enfermedades comórbidas crónicas que recibieron la vacuna contra el COVID-19 informaron tener la intención de recibir dosis de refuerzo.

Palabras clave:
Dosis de refuerzo
Enfermedades comórbidas
COVID-19
Pandemia
Reticencia a la vacunación

Article

These are the options to access the full texts of the publication Vacunas (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Vacunas (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos